Supernus Pharmaceuticals, Inc. (SUPN)
44.21
+0.48
(+1.10%)
USD |
NASDAQ |
Aug 31, 16:00
44.22
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Total Long Term Debt (Quarterly) : 29.43M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 29.43M |
| March 31, 2026 | 30.27M |
| December 31, 2025 | 30.36M |
| September 30, 2025 | 31.42M |
| June 30, 2025 | 24.38M |
| March 31, 2025 | 26.37M |
| December 31, 2024 | 27.38M |
| September 30, 2024 | 28.93M |
| June 30, 2024 | 30.29M |
| March 31, 2024 | 32.99M |
| December 31, 2023 | 33.20M |
| September 30, 2023 | 33.84M |
| June 30, 2023 | 34.18M |
| March 31, 2023 | 36.51M |
| December 31, 2022 | 36.00M |
| September 30, 2022 | 36.03M |
| June 30, 2022 | 38.44M |
| March 31, 2022 | 444.06M |
| December 31, 2021 | 420.55M |
| September 30, 2021 | 420.19M |
| June 30, 2021 | 416.55M |
| March 31, 2021 | 429.51M |
| December 31, 2020 | 427.74M |
| September 30, 2020 | 429.80M |
| June 30, 2020 | 427.02M |
| Date | Value |
|---|---|
| March 31, 2020 | 402.06M |
| December 31, 2019 | 398.10M |
| September 30, 2019 | 391.68M |
| June 30, 2019 | 388.51M |
| March 31, 2019 | 385.52M |
| December 31, 2018 | 354.22M |
| September 30, 2018 | 350.86M |
| June 30, 2018 | 347.45M |
| March 31, 2018 | 344.03M |
| December 31, 2017 | 26.54M |
| September 30, 2017 | 27.96M |
| June 30, 2017 | 30.65M |
| March 31, 2017 | 33.51M |
| December 31, 2016 | 34.56M |
| September 30, 2016 | 5.772M |
| June 30, 2016 | 5.699M |
| March 31, 2016 | 5.627M |
| December 31, 2015 | 37.61M |
| September 30, 2015 | 8.068M |
| June 30, 2015 | 8.608M |
| March 31, 2015 | 11.48M |
| December 31, 2014 | 26.95M |
| September 30, 2014 | 26.50M |
| June 30, 2014 | 28.67M |
| March 31, 2014 | 28.36M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 500.00M |
| Pfizer Inc. | 63.10B |
| Amphastar Pharmaceuticals, Inc. | 679.52M |
| Collegium Pharmaceutical, Inc. | 1.216B |
| Bristol Myers Squibb Co. | 44.59B |